AM-Pharma announces 2.5 million EURO financing
AM-Pharma financing kick-starts Series C financing effort
07-Aug-2007 -
AM-Pharma B.V., a biopharmaceutical company developing improved endogenous proteins to combat disease, announced the signing of a 2.5 million Euro financing agreement with its two main investors, Forbion Capital Partners and Inventages Venture Capital.
The investment is a prelude to a Series C ...
bone marrow
colitis ulcerosa
phase IIa studies
+2